Division of Rheumatology, Allergy and Immunology, Stony Brook University Renaissance School of Medicine, Stony Brook, NY, United States.
Biodata Mining and Discovery Section, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, MD, United States.
Front Immunol. 2023 Oct 19;14:1265404. doi: 10.3389/fimmu.2023.1265404. eCollection 2023.
NOD-like receptors (NLRs) are intracellular sensors associated with systemic autoinflammatory diseases (SAIDs). We investigated the largest monocentric cohort of patients with adult-onset SAIDs for coinheritance of low frequency and rare mutations in and other autoinflammatory genes. Sixty-three patients underwent molecular testing for SAID gene panels after extensive clinical workups. Whole exome sequencing data from the large Atherosclerosis Risk in Communities (ARIC) study of individuals of European-American ancestry were used as control. Of 63 patients, 44 (69.8%) were found to carry combined gene variants in and another gene (Group 1), and 19 (30.2%) were carriers only for variants (Group 2). The genetic variant combinations in SAID patients were digenic in 66% (, , and and oligogenic in 34% of cases. These variant combinations were either absent or significantly less frequent in the control population. By phenotype-genotype correlation, approximately 40% of patients met diagnostic criteria for a specific SAID, and 60% had mixed diagnoses. There were no statistically significant differences in clinical manifestations between the two patient groups except for chest pain. Due to overlapping phenotypes and mixed genotypes, we have suggested a new term, "Mixed NLR-associated Autoinflammatory Disease ", to describe this disease scenario. Gene variant combinations are significant in patients with SAIDs primarily presenting with mixed clinical phenotypes. Our data support the proposition that immunological disease expression is modified by genetic background and environmental exposure. We provide a preliminary framework in diagnosis, management, and interpretation of the clinical scenario.
核苷酸结合寡聚化结构域样受体(NLRs)是与全身炎症性疾病(SAIDs)相关的细胞内传感器。我们研究了最大的单中心成年发病的 SAIDs 患者队列,以研究 NLR 和其他自身炎症基因中低频和罕见突变的共遗传。63 名患者在进行广泛的临床评估后,接受了 SAID 基因谱的分子检测。使用具有欧洲裔美国人血统的大型动脉粥样硬化风险社区(ARIC)研究的个体的外显子组测序数据作为对照。在 63 名患者中,有 44 名(69.8%)患者同时携带 和另一个基因中的联合基因变异(第 1 组),19 名(30.2%)患者仅携带 基因变异(第 2 组)。SAID 患者中的遗传变异组合在 66%的情况下为双基因( 、 、 和 ,在 34%的情况下为寡基因。这些变异组合在对照人群中要么不存在,要么明显频率较低。通过表型-基因型相关性,大约 40%的患者符合特定 SAID 的诊断标准,60%的患者有混合诊断。除胸痛外,两组患者的临床表现无统计学差异。由于表型重叠和混合基因型,我们提出了一个新术语“混合 NLR 相关自身炎症性疾病”来描述这种疾病情况。基因变异组合在主要表现为混合临床表型的 SAIDs 患者中具有重要意义。我们的数据支持免疫性疾病表达受遗传背景和环境暴露影响的观点。我们提供了一个初步的诊断、管理和临床情况解释框架。